iSERA Lifesciences provides prior intimation of a board meeting scheduled for April 20, 2026.
The board will consider and approve a preferential issue of equity shares on a private placement basis.
The disclosure is made pursuant to SEBI LODR Regulations, specifically Regulation 29(1)(d).